| Financial Year |
March 31 2023 |
| Monetary Funds |
1,183,323,194.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
558,484,980.09 |
| Accounts Receivable |
257,397,966.99 |
| Advances to Suppliers |
137,974,130.43 |
| Other Receivables |
15,030,088.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,667,098.81 |
| Inventories |
850,354,478.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,138,209.36 |
| Total Current Assets |
3,131,196,307.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
501,085,456.41 |
| Investment Properties |
18,423,582.45 |
| Fixed Assetes |
4,275,010,690.82 |
| Under-construction Projects |
382,806,647.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
372,110,008.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,193,769.95 |
| Deferred Income Tax Assets |
19,691,516.32 |
| Other Non-Current Assets |
239,537,081.56 |
| Sub-Total of Non-Current Assets |
5,828,736,967.95 |
| Total Assets |
8,959,933,275.61 |
| Short-Term Loans |
889,800,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,639,324.14 |
| Accounts Payable |
322,300,655.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,555,070.44 |
| Taxes Payable |
68,212,278.30 |
| Interest Payable |
-- |
| Dividend Payable |
14,316,225.28 |
| Other payables |
180,585,976.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
380,675,278.60 |
| Other Current Liabilities |
389,637,250.78 |
| Sub-Total of Current Liabilities |
2,408,650,516.27 |
| Long-term Loans |
275,363,396.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
304,343.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
397,716,703.21 |
| Total Liabilities |
2,806,367,219.48 |
| Paid-In Capital(Or Share Stock) |
1,604,703,707.00 |
| Capital Surplus |
3,444,804,277.31 |
| Surplus Reserve |
190,211,756.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
630,852,626.75 |
| Minority Stockholder's Interest |
213,941,154.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,939,624,902.04 |
| Owner's Equity（Stockholder's Equity） |
6,153,566,056.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,959,933,275.61 |
